| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.6M | -33.8% |
| R&D Expense | $94.5M | -13.8% |
| SG&A Expense | $28.4M | -12.4% |
| Operating Income | -$102.7M | +4.8% |
| Pre-tax Income | -$86.6M | +8.0% |
| Income Tax | $0 | -100.0% |
| Net Income | -$86.6M | +12.0% |
| EPS (Basic) | -$1.58 | +32.5% |
| EPS (Diluted) | -$1.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.5M | -31.0% |
| Current Assets | $249.6M | +3.9% |
| Total Assets | $284.0M | -0.7% |
| Current Liabilities | $67.0M | +14.6% |
| Total Liabilities | $329.5M | -9.3% |
| Stockholders' Equity | -$45.5M | +41.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.4M | +15.0% |
| Capital Expenditures | $906K | -26.0% |
| Investing Cash Flow | -$29.9M | -120.7% |
| Financing Cash Flow | $105.4M | +5829.6% |
| Free Cash Flow | -$101.3M | +15.1% |
| +32.5% |